Who Danaher buys from and sells to
Sells bioprocessing consumables (Cytiva), life-science instruments and diagnostics (Cepheid, Beckman Coulter).
Part of GLP-1 and Specialty Pharmaceuticals spending
Buys from 0
None recorded
Sells to 3
- Biologic drug makers and CDMOschromatography resins, filters and single-use bags for antibodies
- Hospital and reference labsCepheid PCR tests and Beckman Coulter analyzers
- Academic and government labsLeica and SCIEX instruments
Where the chain could break
- Bioprocessing revenue swings with biopharma inventory cycles and biologic pipelines
- Respiratory-test demand at Cepheid moves with flu and COVID seasons
- Pending ~$9.9bn Masimo purchase, expected to close in 2H 2026
Competes with
- Thermo FisherTMObioprocess consumables and lab instruments
- Merck KGaAMKKGYMilliporeSigma filters and single-use bioprocessing
- RepligenRGENfiltration and chromatography for biologics
- AbbottABTdiagnostic instruments and assays
Mapped by hand from filings and company reporting, as of October 2026. It shows the relationships that matter most, not every contract: most are never disclosed, and agreements change.